Related Experiment Video
Updated: Jun 19, 2026

Generation of Monocyte-Derived Dendritic Cells with Differing Sialylated Phenotypes
Published on: October 20, 2023
Mannan-binding lectin deficiency increases the risk of recurrent infections in children with Down's syndrome
Renato M Nisihara1, Shirley R R Utiyama, Nanci P Oliveira
1Laboratory of Molecular Immunopathology and Department of Medical Pathology, Federal University of Paraná, Curitiba, Brazil; Evangelical University, Medicine Department, Curitiba, Brazil. iaramessias@yahoo.com.br
Abstract:
Down syndrome (DS) is the most frequent cause of intellectual disability worldwide. DS individuals present abnormalities in the immune system that include high susceptibility to recurrent infections (RI) as well as to autoimmune diseases. Respiratory tract infections remain one of the major causes of death in DS individuals. Mannan-binding lectin (MBL) functions as an opsonina and initiates the lectin complement pathway. MBL deficiency was shown to increase the susceptibility to different infectious diseases, notably by extracellular pathogens. In the present study, MBL circulating levels were evaluated in 150 children with DS from Brazil, to clarify whether MBL deficiency is associated with the presence of RI in these patients. According to the clinical history 30.7% (46/150) of the DS children experienced RI, and MBL deficiency was seen in 34.8% (16/46) of them compared with 13.5% (14/104) of the DS children without RI (p = 0.005, odds ratio = 3.43, 95% confidence interval = 1.5-7.85). Moreover, MBL deficiency was significantly associated with the occurrence of pneumonia when compared with DS without RI (37.5%, 12/32 vs. 13.5% 14/104, p = 0.005, odds ratio = 3.68, 95% confidence interval = 1.5-6.95). These findings demonstrated that MBL deficiency increases the susceptibility to RI in DS patients and that, in the future, they could potentially benefit from MBL therapy.
Insights
Mannan-binding lectin (MBL) deficiency increases recurrent infection risk in children with Down syndrome (DS). Low MBL levels are linked to higher rates of respiratory infections, including pneumonia, in this population.
Area of Science:
- Immunology
- Genetics
- Pediatrics
Background:
- Down syndrome (DS) is associated with immune system abnormalities, leading to increased susceptibility to infections and autoimmune diseases.
- Recurrent respiratory tract infections are a significant cause of mortality in individuals with DS.
- Mannan-binding lectin (MBL) is crucial for innate immunity, initiating the lectin complement pathway and acting as an opsonin.
Purpose of the Study:
- To investigate the association between MBL deficiency and recurrent infections (RI) in Brazilian children with Down syndrome.
- To determine if MBL deficiency is a risk factor for respiratory tract infections in DS patients.
Main Methods:
- Circulating MBL levels were measured in 150 children with DS.
- Clinical history was used to identify children with and without a history of recurrent infections.
- Statistical analysis, including odds ratio and confidence intervals, was performed to assess the association between MBL levels and RI.
Main Results:
- 30.7% of DS children experienced recurrent infections.
- MBL deficiency was significantly more prevalent in DS children with RI (34.8%) compared to those without RI (13.5%) (p = 0.005).
- MBL deficiency was strongly associated with pneumonia in DS patients (37.5% vs. 13.5%, p = 0.005).
Conclusions:
- MBL deficiency is a significant risk factor for recurrent infections, particularly pneumonia, in children with Down syndrome.
- These findings suggest that MBL therapy could be a potential future treatment to reduce infection susceptibility in DS patients.
- Further research into MBL's role in DS immunity is warranted.
More Related Videos
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Humoral Immune Responses
Cytomegalovirus Disease
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Selectins
Inflammatory Bowel Disease III: Crohn's Disease

